![]() |
|
|

*
Graduate Program of Nutritional Sciences and the Institute of Cellular and Molecular Biology, The University of Texas, Austin, TX, 78712 and the
Diabetes and Nutrition Research Group, Institute of Experimental Endocrinology, Slovak Academy of Sciences, Vlarska 3, 833 06 Bratislava, Slovak Republic.
2To whom correspondence should be addressed.
| ABSTRACT |
|---|
|
|
|---|
hydroxylase
mRNA, respectively. hepatic These data indicate that a Cu deficiency
stimulates hepatic lipogenic gene expression by increasing the hepatic
translocation of mature SREBP-1.
KEY WORDS: sterol regulatory element binding protein copper fatty acid synthase rats
| INTRODUCTION |
|---|
|
|
|---|
Although the induction of hepatic lipid synthesis and secretion
accompanying a Cu deficiency may be secondary to hepatic iron
enrichment, this still does not explain the cellular and molecular
mechanisms responsible for the increase in hepatic lipid synthesis. In
part the answer to this question resides in our observation that a
dietary Cu deficiency induces transcription of lipogenic genes, that
is, fatty acid synthase, and that this in turn increases fatty acid
synthase mRNA abundance and finally elevates fatty acid synthase
enzymatic activity (Wilson et al. 1997
). How Cu
deficiency and possibly iron overload coordinately induce the hepatic
expression of genes encoding enzymes involved in fatty acid and
cholesterol biosynthesis remains unclear. We hypothesized that Cu
deficiency alters the protein/DNA interactions of transcription factors
that are essential for fatty acid synthase gene transcription and that
these changes in protein/DNA interactions alter chromatin structure
such that fatty acid synthase promoter activity is increased.
| MATERIALS AND METHODS |
|---|
|
|
|---|
The basal diet was purchased from Dyets (Bethlehem, PA) and was
formulated according to the AIN-93-G rodent diet (Reeves et al. 1993
) recommendations. The composition of the diet was
specifically modified by using sucrose instead of dextrose and by the
omission of Cu from the mineral mix. The basal diet, which contained
0.6 mg Cu/kg, served as the Cu-deficient diet, whereas the
Cu-adequate diet was prepared by supplementing the basal diet with
CuSO4 · 5H2O to a concentration of 6.0 mg/kg.
Weanling male Sprague-Dawley rats (Harlan Sprague-Dawley, Indianapolis, IN) weighing 4055 g were housed individually in stainless steel mesh cages in an animal facility maintained at 24°C and 12/12-hour reversed light-dark cycle. Distilled water was provided in polyethylene bottles. During a 7-d adaptation period, food intake and body weight changes were determined daily. After this adaptation period, rats were paired according to food intake and weight gain. Each pair of rats was pair meal fed (8 h/d, 10001800 h) the Cu-deficient or Cu-adequate diet for 28 d. Food was allotted to Cu-adequate rats by giving an amount of Cu-adequate diet equal to that consumed on the previous day by its Cu-deficient pair. Body weights were measured once a week. Rats were killed and livers were collected for analysis 16 h after their last meal.
DNase I hypersensitivity site mapping.
Rat liver nuclei were prepared as previously described
(Rongnoparut et al. 1991
). Briefly, 5 g liver was
homogenized in 30 mL homogenization buffer [10 mmol HEPES/L (pH 7.6),
25 mmol KCl/L, 1 mmol sodium EDTA/L, 2 mol sucrose/L, 10% (v/v)
glycerol, 0.15 mmol spermine/L and 2 mmol spermidine/L]. The
homogenate was centrifuged through a 10-mL 2. 0 mol sucrose/L cushion
[10 mmol HEPES/L (pH 7.6), 25 mmol KCl/L, 1 mmol sodium EDTA/L, 2 mol
sucrose/L, 10% (v/v) glycerol, 0.15 mmol spermine/L and 2 mmol
spermidine/L] at 75,000 x g for 1 h at
4°C. DNase I hypersensitivity site mapping of the 5'-flanking region
of the fatty acid synthase gene was conducted as previously described
(Jump et al. 1987
). Briefly, 100 µL
(500 µg) nuclei was digested in a buffer (0.25 mol
sucrose/L, 15 mmol Tris-Cl/L [pH 8.0], 60 mmol KCl/L, 3 mmol
MgCl2/L) that contained 020 U DNase I (Promega, Madison,
WI). After 5 min of digestion at 30°C, the reaction was stopped by
adding 10 µL 0.5 mol EDTA/L, and the nuclei were then
incubated with RNase A (50 mg/L; Promega) for 1 h at 37°C. After
RNase A digestion, 330 µL proteinase K digestion
buffer [0.15% SDS, 100 mg proteinase K/L (Promega), 10 mmol/TrisHCl
(pH 7.5), 0.1 mol NaCl/L, 0.1 mmol EDTA/L] was added and incubated at
37°C overnight. DNA (15 µg) isolated from above
nuclei was completely digested with BamHI (Promega). The
digested fragments were size-fractionated by electrophoresis in
0.7% agarose gel. The DNA was electrotransferred onto ZetaProbe GT
blotting membrane (BioRad, Hercules, CA). Blots were hybridized with
32P-labeled probes (NEN, Boston, MA) corresponding to the
fatty acid synthase gene regions of (a) -5421 to 5050; (b) -4949 to
-4651 and (c) -2711 to -2378. Hybridization was visualized by
exposing the blots to X-OMAT AR film (Kodak, Rochester, NY) for
2 d at -80°C.
DNase I footprinting analysis.
Hepatic nuclear proteins were isolated as described previously
(Rongnoparut et al. 1991
). Briefly, 5 g liver was
homogenized in 30-mL of homogenization buffer [10 mmol HEPES/L (pH
7.6), 25 mmol KCl/L, 1 mmol sodium EDTA/L, 2 mol sucrose/L, 10% (v/v)
glycerol, 0.15 mmol spermine/L and 2 mmol spermidine/L]. The
homogenate was layered over a 10-mL cushion of homogenization buffer
and was centrifuged at 75,000 x g for 1 h at
4°C. The nuclear pellet was resuspended in 10 mL of lysis buffer [10
mmol HEPES/L (pH 7.6), 100 mmol KCl/L, 2 mmol MgCl2/L, 1
mmol EDTA/L, 1 mmol dithiothreitol/L and 10% (v/v) glycerol]. After
the addition of 1 mL ammonium sulfate (4 mol/L, pH 7.9), the suspension
was centrifuged at 75,000 x g for 45 min at 4°C.
Solid ammonium sulfate (300 g/L) was added to the supernatant and was
slowly dissolved for 15 min. After an additional 30 min on ice, it was
centrifuged at 75,000 x g for 1 h at 4°C.
The protein pellet was resuspended in dialysis buffer [10 mmol HEPES/L
(pH 7.6), 40 mmol KCl/L, 0.1 mmol EDTA/L, 1 mmol dithiothreitol/L and
10% (v/v) glycerol] at 1 mL per 40 A260 U and subsequently dialyzed
twice for 2 h against 250 mL of dialysis buffer.
DNase I footprinting was carried out by a modification of a previously
described procedure (Rongnoparut et al. 1991
). The
-265/+65 fatty acid synthase fragment was labeled using klenow
fragment (Clontech, San Francisco, CA) and
[
-32P]dATP (NEN) to fill in the
Sau3AI cut site at the 3'-flanking end and then was
purified using Spin column (BioRad). Protein binding to the DNA
fragment was conducted by incubating nuclear extracts with 75,000 dpm
(0.51 ng) of probe in 50 µL of reaction buffer [50
mmol NaCl/L, 0.1 mmol EDTA/L, 20 mmol HEPES/L (pH 7.5), 0.5 mmol
dithiothreitol/L and 10% glycerol]. After a 30-min incubation at room
temperature, 6 µL of 0.1 mol MgCl2/L, 20
mmol CaCl2/L and 0.05 U of DNase I was added to the
reaction. The reaction was stopped after 1 min by the addition of 20
µL of 0.1 mol EDTA/L (pH 7.6). The sample was
extracted with phenol/chloroform and the DNA precipitated with ethanol.
The DNA precipitate was resuspended in 95% formamide and resolved on a
5% polyacrylamide 8 mol/L urea sequence gel. The footprint was
visualized by exposing the dried gel to X-OMAT AR film (Kodak) for
2 d at -80°C.
Western blot analysis.
Microsomal and nuclear proteins were isolated from liver removed from
rats as described previously (Sheng et al. 1995
).
Briefly, 5 g liver was homogenized in 30 mL of buffer A [10 mmol
HEPES/L (pH 7.6), 25 mmol KCl/L, 1 mmol sodium EDTA/L, 2 mol sucrose/L,
10% (v/v) glycerol, 0.15 mmol spermine/L, 2 mmol spermidine/L, 50 mg/L
N-acetylleucylnorleucinal (Roche, Indianapolis, IN), 20
mg pefabloc/L (Roche), 5 mg pepstain A/L (Roche), 10 mg leupeptin/L
(Roche) and 2 mg aprotinin/L (Roche)]. The homogenate was layered over
a 10-mL cushion of buffer A and was centrifuged at 75,000 x g for 1 h at 4°C. The resultant pellet (nuclei)
was resuspended in 1 mL of buffer B [10 mmol HEPES/L (pH 7.6), 100
mmol KCl/L, 2 mmol MgCl2/L, 1 mmol EDTA/L, 1 mmol
dithiothreitol/L, 10% (v/v) glycerol, 50 mg
N-acetylleucylnorleucinal/L (Roche), 20 mg pefabloc/L
(Roche), 5 mg pepstain A/L (Roche), 10 mg leupeptin/L (Roche) and 2 mg
aprotinin/L (Roche)]. After the addition of 100 µL
ammonium sulfate (4 mol/L, pH 7.9) the suspension was centrifuged at
257,000 x g for 45 min at 4°C. The resultant
supernatant was collected as nuclear protein extract. To isolate
microsomal membranes, 1 g liver was homogenized in 5 mL
homogenization buffer [20 mmol/L TrisHCl (pH 8.0), 150 mmol NaCl/L,
1 mmol CaCl2/L, 50 mg
N-acetylleucylnorleucinal/L (Roche), 20 mg pefabloc/L
(Roche), 5 mg pepstain A/L (Roche), 10 mg leupeptin/L (Roche) and 2 mg
aprotinin/L (Roche)]. The homogenate was centrifuged at 800 x g for 10 min at 4°C. The resultant supernatant was
used to isolate microsomal membranes by centrifuging the supernatant
for 1 h, 100,000 x g at 4°C. The pellet was
rinsed with homogenization buffer and subsequently resuspended in 1.5
mL 250 mmol TrisHCl/L, pH 6.0, and 2 mmol CaCl2/L. The
membrane proteins were extracted by adding an equal volume of 2 mmol
CaCl2/L, 320 mmol NaCl/L, 2% Triton X-100, 20 mg
pefabloc/L (Roche), 5 mg pepstain A/L (Roche), 10 mg leupeptin/L
(Roche) and 2 mg aprotinin/L (Roche) to the membrane pellet, mixing,
and subsequently centrifuging the suspension for 45 min, 100,000
x g at 4°C.
Western immunoblot analyses for SREBP-1 and USF-1 were carried out as
previously described (Towbin et al. 1979
). Aliquots (50
µg protein) of microsomal or nuclear extract were
subjected to 8% SDSPAGE gel, transferred to nitrocellulose
(Bio-Rad), and incubated with either monoclonal antiSREBP-1 (IgG-2A4)
prepared from hybridoma cells (American Type Culture Collection,
Rockville, MA) or 0.1 mg/L antiUSF-1 (Santa Cruz Biotechnology, Santa
Cruz, CA) for 2 h at room temperature. The immunoreactive SREBP-1
and USF-1 were visualized with the enhanced chemiluminescence Western
Blotting Detection System kits (Amersham, Arlington Heights, IL). Bands
were quantified for relative intensity using the Ambis visual imaging
4000 system (AMBIS, San Diego, CA).
Northern blot analysis.
Total RNA was prepared from rat liver using the
phenol-guanidinium-isothiocyanate procedure (Chomczynski and Sacchi 1987
). For Northern gel analysis, 30 µg
of total RNA was denatured, subjected to electrophoresis in 1.2%
agarose gel and transferred onto Zeta Probe GT membrane (Bio-Rad). The
abundance of the respective transcript was determined by sequentially
hybridizing the membrane with radiolabeled cDNA probes using the
following: hamster SREBP-1 (American Type Culture Collection cDNA Clone
No. 87012), rat fatty acid synthase (Wilson et al. 1997
), mouse cytoplasmic hydroxymethyglutaryl-CoA synthase
(Gene-Bank Accession No.W85267), mouse cholesterol
7-
-hydroxylase (Gene-Bank Accession No. AA 254999)
and human glyceraldehyde-3-phosphate dehydrogenase (American Type Culture Collection cDNA Clone No. 2007254). Each cDNA was labeled with
[
-32P]dCTP (NEN) using random prime
labeling kits (GIBCO-BRL, Grand Island, NE). Hybridization was
conducted overnight at 40°C or 42°C and was exposed at -80°C to
Kodak X-Omat ARTM film (Kodak) with intensifying screens for 1272
h. Corrections for variation in RNA loading of each lane were made
using glyceraldehyde-3-phosphate dehydrogenase mRNA as the reference
transcript.
Statistical analysis.
The significance of the compared mean values was determined using two-tailed Students t test. Data are presented as mean ± SEM, and P < 0.05 is considered significant.
| RESULTS |
|---|
|
|
|---|
The impact of the Cu-deficient diet on DNA-protein interactions
within the 5'-flanking region of the hepatic fatty acid synthase gene
was examined using DNase I hypersensitivity site mapping (Fig. 1
) and in vitro footprinting (Fig. 2
). DNase I hypersensitivity sites represent regions of local
discontinuity in the DNA-protein interactions along the chromatin
fiber (Gross and Garrard 1988
, Paranjape et al. 1994
). Such sites typically identify regions within the genes
that are actively involved in the regulation of gene transcription
(Jump et al. 1987
). Application of the DNase I
hypersensitivity mapping technique to nuclei prepared from the livers
of Cu-deficient and -adequate rats revealed that the 5'-flanking
region of the fatty acid synthase gene contained four major
hypersensitivity sites (HSS) within the region of -9700 to +658 (Fig. 1)
. The four sites mapped to the following regions: (a) -8700 to
-8600 (HSS 1); (b) -7300 to -6900 (HSS 2); (c) -600 to -400 (HSS
3) and (d) -100 to +50 (HSS 4). The transcription factors that
interact with HSS 1 and HSS 2 remain to be defined. HSS 3 reportedly
contains cis-elements that enhance promoter activity in
response to insulin (Roder et al. 1997
). The sequences
within HSS 4 instill insulin and sterol response to the fatty acid
synthase promoter (Marisa and Osborne 1996
,
Moustaid et al. 1994
). Because Cu deficiency alters
hepatic cholesterol homeostasis (Al-Othman et al. 1994
,
Croswell and Lei 1985
, Lefevre et al. 1986
, Samman and Roberts 1985
), the HSS 4 region
was utilized in an in vitro footprint analysis to evaluate the impact
of dietary Cu deficiency on protein-DNA interaction (Fig. 2)
.
Hepatic nuclear proteins prepared from Cu-adequate rats weakly
bound to the region of -88 to -78 and -68 to -58, which are the DNA
recognition sites for Sp1 and SREBP-1, respectively (Fig. 2)
.
On the other hand, DNA binding activity was much greater in nuclear
protein extracts from Cu-deficient rats as can be seen by the very
clear footprint in these respective regions, between -58 and -68 and
between -78 and -88 (Fig. 2)
.
|
|
The in vitro footprint of the HSS 4 region suggested that DNA sequence
between -85 and -55 may play a role in the Cu-dependent
regulation of fatty acid synthase gene transcription. This region of
the proximal promoter of the fatty acid synthase gene contains DNA
binding sites for USF-1 and SREBP-1 (Marisa and Osborne 1996
). Western blot analysis revealed that the nuclear content
of USF-1 was unaffected by a dietary Cu deficiency (Fig. 3
). In contrast, the nuclear content of mature SREBP-1 was 150% greater
in nuclei from Cu-deficient rats than from Cu-adequate rats
(Fig. 4
). This increase in nuclear concentration of mature SREBP-1 associated
with a Cu deficiency was paralleled by a significant decrease in the
hepatic content of membrane anchored precursor SREBP-1 (Fig. 5
). However, the reduction in precursor SREBP-1 protein was not
paralleled by a decrease in the hepatic abundance of SREBP-1 mRNA
(Fig. 6
). The 150% increase in nuclear content of mature SREBP-1 in the liver
of Cu-deficient rats was accompanied by a threefold increase in
hepatic fatty acid synthase mRNA abundance and an 80% decrease in the
hepatic content of cholesterol 7-
hydroxylase mRNA.
Surprisingly, the mRNA abundance for the cholesterologenic enzyme
cytosolic HMG-CoA synthase was unaffected by dietary Cu status
(Fig. 6)
.
|
|
|
|
| DISCUSSION |
|---|
|
|
|---|
hydroxylase (Horton et al. 1998
hydroxylase
>80% (Fig. 6)
The nuclear content of mature SREBP-1 is dependent on the synthesis of
SREBP-1 precursor and/or the proteolytic release of the mature SREBP-1
from its endoplasmic reticulumanchored precursor
(Brown and Goldstein 1999
). SREBP-1 is
synthesized as a 125-kDa precursor that contains two
trans-membrane domains that allow the protein to be anchored
in the endoplasmic reticulum (Brown and Goldstein 1999
).
The 480 amino acid N-terminal domain corresponds to the mature
SREBP-1 transcription factor and is released from the endoplasmic
reticulum membrane by a two-step proteolytic cascade (Brown and Goldstein 1999
). The observation that the dietary Cu
deficiency was associated with a 2.5-fold increase in the nuclear
content of SREBP-1 and a concomitant 45% reduction in membrane content
of SREBP-1 precursor indicates that the Cu deficiency enhanced the
proteolytic release and nuclear translocation of mature SREBP-1. This
conclusion is strengthened by the observation that the hepatic
abundance of SREBP-1 mRNA was not affected by the dietary Cu deficiency
(Fig. 6)
.
The mechanism by which Cu deficiency enhances the nuclear localization
of SREBP-1 may be related to the observation that Cu deficiency reduces
hepatic cholesterol levels by as much as 50%. The proteolytic release
of mature SREBP-1 may be dependent on the amount of cholesterol that is
located in the endoplasmic reticulum (Brown and Goldstein 1999
). As cholesterol is depleted from the endoplasmic
reticulum membrane, the sterol-regulated protease within the lumen
of the endoplasmic reticulum is activated, which in turn leads to the
severing of the peptide anchor and subsequent release of the mature
form of the SREBP-1. Such sterol control of SERBP-1 release is
consistent with the increase in nuclear content of mature SREBP-1 and
the decrease in the membrane amount of SREBP-1 that we observed in the
livers of Cu-deficient rats. Thus, it appears that dietary Cu
status may upregulate genes encoding enzymes of lipogenesis by
decreasing the hepatic content of cholesterol and thereby increasing
the nuclear content of SREBP-1. However, one thing remains to be
explained, how cholesterol is depleted from the liver in a dietary Cu
deficiency when the expression of the rate-limiting enzyme in bile
acid synthesis (that is, cholesterol 7-
hydroxylase) is
markedly suppressed. Wu et al. (1997)
have argued that the enhanced
expression of hepatic apolipoprotein A-I observed in a Cu
deficiency results in diversion of cholesterol away from bile acid
synthesis and into lipoprotein assembly and secretion. Such a diversion
may explain the depletion of hepatic cholesterol that occurs in a Cu
deficiency and offers one explanation for the increase in nuclear
concentrations of SREBP-1. An alternative explanation for the
increase in nuclear content of SREBP-1 may lie with the observations
that the hepatic concentration of reduced glutathione is increased
5080% in the liver of Cu-deficient rats (Kim et al. 1992
) and that the hepatic expression of fatty acid synthase is
induced by an elevation in hepatic reduced glutathione (Wilson et al. 1997
). Reduced glutathione inhibits neutral
sphingomyelinase (Liu and Hannun 1998
).
Moreover, activation of sphingomyelinase is associated with a decreased
proteolytic release of SREBP (Scheek et al. 1997
). Thus,
the increase in hepatic reduced glutathione associated with Cu
deficiency may suppress the activity of neutral sphingomyelinase and
thereby lead to an enhance the proteolytic release of SREBP-1. The
consequence would be to stimulate fatty acid synthase gene
transcription while suppressing the expression of cholesterol 7-
hydroxylase. Although this mechanism is only a hypothesis, it may offer
an explanation for how Cu deficiency coordinately regulates the
gene-encoding proteins that are involved in lipid and cholesterol
metabolism and transport.
| FOOTNOTES |
|---|
3 Abbreviations
used: CuD, copper deficiency; CuA, copper adequate; FAS, fatty
acid synthase; HMG-CoA, hydroxymethylglutaryl-CoA; hypersensitivity
site, HSS; SREBP, sterol regulatory element binding protein; USF-1,
upstream stimulatory factor-1. ![]()
Manuscript received March 30, 2000. Initial review completed June 6, 2000. Revision accepted August 11, 2000.
| REFERENCES |
|---|
|
|
|---|
1. Allen K.G.D., Klevay L. M. Cholesterolemia and cardiovascular abnormalities in rats caused by copper deficiency. Atherosclerosis 1978a;29:81-93[Medline]
2. Allen K.G.D., Klevay L. M. Copper deficiency and cholesterol metabolism in the rat. Atherosclerosis 1978b;31:259-271[Medline]
3. Al-Othman A., Rosenstein F., Lei K. Y. Copper deficiency alters plasma pool size, percent composition and concentration of lipoprotein components in rats. J. Nutr. 1992;122:1199-1204
4. Al-Othman A., Rosenstein F., Lei K. Y. Copper deficiency increases in vivo hepatic synthesis of fatty acids, triacylglycerols, and phospholipids in rats. Proc. Soc. Exp. Biol. Med. 1993;204:97-103[Abstract]
5. Al-Othman A., Rosenstein F., Lei K. Y. Pool size and concentration of plasma cholesterol are increased and tissue copper levels are reduced during early stages of copper deficiency in rats. J. Nutr. 1994;124:628-635
6. Bala S., Failla M. L., Lunney J. K. Alterations in splenic lymphoid cell subsets and activation antigens in copper-deficient rats. J. Nutr. 1991;121:745-753
7.
Bennett K. M., Lopez J. M., Sanchez H. B., Osborne T. F. Sterol regulation of fatty acid synthase promoter. J. Biol. Chem. 1995;270:25578-25583
8.
Brown M. S., Goldstein J. L. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc. Natl. Acad. Sci. USA. 1999;96:11041-11048
9. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987;162:156-159[Medline]
10. Croswell S. C., Lei K. Y. Effect of copper deficiency on the apo lipoprotein E-rich high density lipoproteins in the rats. J. Nutr. 1985;115:473-482
11. Dabbagh A. J., Mannion T., Lynch S. M., Frei B. The effect of iron overload on rat plasma and liver oxidant status in vivo. Biochem. J. 1994;300:799-803
12. Gross D. S., Garrard W. T. Nuclease hypersensitivity sites in chromatin. Annu. Rev. Biochem. 1988;57:159-197[Medline]
13. Fields M., Lewis C. G. Hepatic iron overload may contribute to hypertriglyceridemia and hypercholesterolemia in copper-deficient rats. Metabolism 1997;46:377-381[Medline]
14.
Fields M., Lewis C. G., Alcantara O., Obeid L., Hannum Y., Ponka P., Boldt D. H. Regulation of protein kinase C expression by iron. Blood 1994;84:3510-3517
15. Fields M., Lure M. D., Lewis C. G. The effect of saturated fat vs unsaturated fat on the pathogenesis of copper deficiency in rats. J. Nutr. Biochem. 1996;7:246-251
16. Horton J. D., Shimomura L., Brown M. S., Hammer R. E., Goldstein J. L., Shimano H. Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J. Clin. Invest. 1998;101:2331-2339[Medline]
17.
Jump D. B., Wong N.C.W., Oppenheimer J. H. Chromatin structure analysis and methylation state of thyroid hormone-responsive gene in rats liver. J. Biol. Chem. 1987;262:778-784
18. Kim S. B., Chao P. Y., Allen K.G.D. Inhibition of elevated hepatic glutathione abolishes copper deficiency cholesterolemia. FASEB J 1992;6:2467-2471[Abstract]
19. Klevay L. M., Inman L., Johnson L. K., Lawler M., Mahalko J. R., Milne D. B., Lukaski H. C., Bolonchuk W., Sandstead H. H. Increased cholesterol in plasma in a young man during experimental copper depletion. Metabolism 1984;33:1112-1118[Medline]
20. Lefevre M., Keen C. L., Lonnerdal B., Hurley L. S., Schneeman B. O. Copper deficiency-induced hypercholesterolemia: effects on HDL subfractions and hepatic lipoprotein receptor activity in the rats. J. Nutr. 1986;116:1735-1746
21.
Liu B., Hannun Y. A. Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J. Biol. Chem. 1997;272:16281-16287
22.
Marisa M., Osborne T. F. Two tandem binding sites for sterol regulatory element binding proteins are required for sterol regulation of fatty acid synthase. J. Biol. Chem. 1996;271:32689-32694
23.
Moustaid N., Beyer R. S., Sul H. S. Identification of an insulin response element in the fatty acid synthase promoter. J. Biol. Chem. 1994;269:5629-5634
24. Nelson S. K., Huang C. J., Mathias M. M., Allen K.G.D. Copper-marginal and copper-deficient diets decrease aortic prostacyclin production and copper-dependent superoxide dismutase activity and increase aortic lipid peroxidation in rats. J. Nutr. 1992;122:2101-2108
25. Paranjape S. M., Kamakaka R. T., Kadonaga J. T. Role of chromatin structure in the regulation of transcription by RNA polymerase II. Annu. Rev. Biochem. 1994;63:265-297[Medline]
26. Paynter D. I., Moir R. J., Underwood E. J. Changes in activity of the Cu, Zn superoxide dismutase enzyme in tissue of the rat with changes in dietary copper. J. Nutr. 1979;122:1570-1576
27. Prohaska J. R. Biochemical changes in copper deficiency. J. Nutr. Biochem. 1990;1:452-461
28. Reeves P. G., Nielsen F. H., Fahey G. C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 1993;123:1939-1951
29.
Roder K., Wolf S. S., Beck K. F., Schweizer M. Cooperative binding of NF-Y and Sp 1 at the DNase I-hypersensitive site, fatty acid synthase insulin-responsive element 1, located at -500 in the rat fatty acid synthase promoter. J. Biol. Chem. 1997;272:21616-21624
30.
Rongnoparut P., Verdon C., Gehnrich S. C., Sul H. S. Isolation and characterization of the transcriptionally regulated mouse liver (ß-type) phosphofructokinase gene and its promoter. J. Biol. Chem. 1991;266:8086-8091
31.
Rucker R. B., Murray J. Cross-linking amino acids in collagen and elastin. Am. J. Clin. Nutr. 1978;31:1221-1236
32. Rufo C., Gasperikova D., Clarke S. D., Garcia M. T., Nakamura M. T. Identification of a novel enhancer sequence in the distal promoter of the rat fatty acid synthase gene. Biochem. Biophys. Res. Commun. 1999;261:400-405[Medline]
33. Samman S., Roberts D.C.K. Dietary copper and cholesterol metabolism. Nutr. Res. 1985;5:1021-1034
34.
Scheek S., Brown M. S., Goldstein J. L. Sphingomyelin depletion in cultured cells blocks proteolysis of sterol regulatory element binding proteins at site 1. Proc. Natl. Acad. Sci. USA. 1997;94:11179-11183
35. Shao M.J.S., Lei K. Y. Conversion of 2-14C-mevalonate into cholesterol, lanosterol, and squalene in copper deficient rats. J. Nutr. 1980;110:859-867
36.
Sheng Z., Otani H., Brown M. S., Goldstein J. L. Independent regulation of sterol regulatory element-binding proteins 1 and 2 in hamster liver. Proc. Natl. Acad. Sci. USA. 1995;92:935-938
37. Shimano H., Horton J. D., Hammer R. E., Shimomura L., Brown M. S., Goldstein J. L. Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J. Clin. Invest. 1996;98:1575-1584[Medline]
38.
Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 1979;76:4350-4354
39.
Wang D., Sul H. S. Upstream stimulatory factor binding to the E-box at -65 is required for insulin regulation of the fatty acid synthase promoter. J. Biol. Chem. 1997;272:26367-26374
40.
Wilson J., Kim S. B., Allen K.G.D., Ballie R., Clarke S. D. Hepatic fatty acids synthase gene transcription is induced by a dietary copper deficiency. Am. J. Physiol. 1997;272:E1124-E1129
41.
Wu Y. J., Zhang J. J., Wang Y., Reaves S. K., Lei K. Y. Regulation of apolipoprotein A-I gene expression in Hep G2 cells depleted of Cu by cupruretic tetramine. Am. J. Physiol. 1997;273:C1362-C1370
42.
Xu J., Nakamura M. T., Cho H. P., Clarke S. D. Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. J. Biol. Chem. 1999;274:23577-23583
43. Yieh L., Sanchez H. B., Osborne T. F. Domains of transcription factor Sp 1 required for synergistic activation with sterol regulatory element binding protein 1 of low density lipoprotein receptor promoter. Proc. Natl. Acad. Sci. USA. 1995;20:6102-6106
This article has been cited by other articles:
![]() |
H. tom Dieck, F. Doring, H.-P. Roth, and H. Daniel Changes in Rat Hepatic Gene Expression in Response to Zinc Deficiency as Assessed by DNA Arrays J. Nutr., April 1, 2003; 133(4): 1004 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Lee, T. E. Engle, and K. L. Hossner Effects of dietary copper on the expression of lipogenic genes and metabolic hormones in steers J Anim Sci, July 1, 2002; 80(7): 1999 - 2005. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||